Insmed Inc’s filing revealed that its Chief Legal Officer Smith Michael Alexander unloaded Company’s shares for reported $3.49 million on Sep 02 ’25. In the deal valued at $143.89 per share,24,272 shares were sold. As a result of this transaction, Smith Michael Alexander now holds 54,902 shares worth roughly $7.97 million.
Then, Flammer Martina M.D. sold 186,648 shares, generating $26,941,272 in total proceeds. Upon selling the shares at $144.34, the Chief Medical Officer now owns 83,111 shares.
Before that, Flammer Martina M.D. bought 186,648 shares. Insmed Inc shares valued at $26,935,498 were divested by the Officer at a price of $144.31 per share.
William Blair initiated its Insmed Inc [INSM] rating to an Outperform in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who decreased its forecast for the stock in mid August from “an Overweight” to “an Equal-weight”. Jefferies began covering INSM with “Buy” recommendation on May 13, 2025. RBC Capital Mkts started covering the stock on February 25, 2025. It rated INSM as “an Outperform”.
Price Performance Review of INSM
On Friday, Insmed Inc [NASDAQ:INSM] saw its stock jump 1.80% to $145.1. Over the last five days, the stock has gained 7.51%. Insmed Inc shares have risen nearly 97.94% since the year began. Nevertheless, the stocks have risen 110.17% over the past one year. While a 52-week high of $146.84 was reached on 09/03/25, a 52-week low of $60.40 was recorded on 04/09/25.
Levels Of Support And Resistance For INSM Stock
The 24-hour chart illustrates a support level at 141.89, which if violated will result in even more drops to 138.67. On the upside, there is a resistance level at 146.75. A further resistance level may holdings at 148.40.
How much short interest is there in Insmed Inc?
A steep rise in short interest was recorded in Insmed Inc stocks on 2025-08-15, growing by 0.81 million shares to a total of 10.5 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 9.69 million shares. There was a rise of 7.7%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on April 23, 2024 when Truist began covering the stock and recommended ‘”a Buy”‘ rating along with a $48 price target.
